Champions Oncology vs Precipio
Champions Oncology and Precipio are similar in size: $59.4m and $53.5m of revenue in their latest fiscal years. Precipio grew faster (28.0% against 4.4%). Precipio kept more of each dollar of sales as profit: a net margin of -0.7% against -2.0%. Champions Oncology carries less debt relative to equity (0.0% against 0.6%).
| Latest fiscal year | Champions OncologyCSBR, 2026 | PrecipioPRPO, 2025 |
|---|---|---|
| Revenue | $59.4m | $53.5m |
| Revenue growth | 4.4% | 28.0% |
| Net income | −$1.2m | −$363,000 |
| Operating margin | -1.9% | -2.2% |
| Net margin | -2.0% | -0.7% |
| Return on equity | -30.5% | -2.7% |
| Free cash flow | −$5.0m | $359,000 |
| Cash | $4.9m | $2.7m |
| Total debt | $0 | $83,000 |
| Debt to equity | 0.0% | 0.6% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 214 | — |
| Market value | $67.6m | $33.5m |
| Price vs our value range | — | — |
| Moat score | 63 (Moderate) | 12 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 3 buys, 4 sales |